Skip To Main Content
Paul Volberding on Muck Rack

Paul Volberding

Verified
San Francisco
As seen in: Current HIV/AIDS Reports, Journal of Acquired Immune Deficiency Syndrome, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, Medscape, National Academies of Sciences, Healio Primary Care, HemOnc Today, Infectious Diseases News, Citeline, cn1699.com
I'm a cancer specialist by training but have been deeply involved in the HIV epidemic from the beginning. I'm committed to ending this epidemic.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

New HIV infections would soar if Ryan White program went away

|
By Anthony Stitt Verified, Kristen Dowd Verified, Paul Volberding Verified
| Citeline Verified
Key takeaways: A modeling study showed HIV infections would increase by 73% if the program ended. A clinician says the program is “absolutely critical” to control HIV. DENVER — Melissa Schnure, PhD, wants to make sure some of the country’s most vulnerable patients are protected — low-income people living with HIV who depend on federally funded HIV services.
Open in Who Shared View Duplicates (3) Issue with article?

IDWeek essential as ever amid increased focus on specialty

|
By Caitlyn Stulpin Verified, Paul Volberding Verified
| Infectious Diseases News Verified
Key takeaways: IDWeek 2025 will be held at the Georgia World Congress Center in Atlanta from Oct. 19 to 22. Areas to watch closely at the meeting include vaccines, COVID-19, HIV and antimicrobial resistance. Healio is on-site again for IDWeek, which is being held at the Georgia World Congress Center in Atlanta from Oct. 19 to 22.
Open in Who Shared Issue with article?

Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings

|
By Paul Volberding Verified, Jennifer Koop, Carol Mason Spicer
| National Academies of Sciences
This is the first of two reports requested by the Social Security Administration (SSA) to address best practices and community experiences in the management and treatment of sickle cell disease (SCD). SCD, a group of inherited blood disorders affecting approximately 100,000 people in the United States, is a chronic, life-long condition that affects every organ system in the body.
Open in Who Shared Issue with article?
See all 41 articles